Literature DB >> 19468012

Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy.

Kazumasa Unno1, Satoshi Isobe, Hideo Izawa, Xian Wu Cheng, Masakazu Kobayashi, Akihiro Hirashiki, Takashi Yamada, Ken Harada, Satoru Ohshima, Akiko Noda, Kohzo Nagata, Katsuhiko Kato, Mitsuhiro Yokota, Toyoaki Murohara.   

Abstract

AIMS: To examine the relation between mitochondrial dysfunction and myocardial contractile and relaxation reserves in hypertrophic cardiomyopathy (HCM). METHODS AND
RESULTS: Thirty HCM patients (LVEF >or=60%) underwent biventricular cardiac catheterization analysis both at rest and during atrial pacing as well as myocardial (99m)Tc-sestamibi scintigraphy at rest to calculate washout rate. Endomyocardial biopsy specimens were obtained for quantitative mRNA analysis and electron microscopy. The HCM patients were divided into two groups-group A: normal force-frequency relation and a pressure half-time (T(1/2)) of <30 ms (n = 15); group B: abnormal force-frequency relation or T(1/2) of >or=30 ms (n = 15). The (99m)Tc-sestamibi washout rate was significantly correlated with T(1/2) for all patients (r = 0.74, P < 0.01) and was also significantly greater in group B (29.2 +/- 6.3%) than in group A (19.3 +/- 3.1%). The abundance of mRNAs for mitochondrial electron transport-related enzymes was significantly higher in group A than in group B. Mitochondria showed a greater variation in size and were more disorganized in group B than in group A.
CONCLUSION: Mitochondria showed functional impairment and morphological disorganization in the left ventricle of HCM patients without baseline systolic dysfunction. These mitochondrial changes were associated with impaired myocardial contractile and relaxation reserves.

Entities:  

Mesh:

Year:  2009        PMID: 19468012     DOI: 10.1093/eurheartj/ehp184

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  14 in total

Review 1.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

3.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

4.  Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.

Authors:  Sara Ranjbarvaziri; Kristina B Kooiker; Mathew Ellenberger; Giovanni Fajardo; Mingming Zhao; Alison Schroer Vander Roest; Rahel A Woldeyes; Tiffany T Koyano; Robyn Fong; Ning Ma; Lei Tian; Gavin M Traber; Frandics Chan; John Perrino; Sushma Reddy; Wah Chiu; Joseph C Wu; Joseph Y Woo; Kathleen M Ruppel; James A Spudich; Michael P Snyder; Kévin Contrepois; Daniel Bernstein
Journal:  Circulation       Date:  2021-10-21       Impact factor: 39.918

Review 5.  Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.

Authors:  Daniel J Philipson; Eugene C DePasquale; Eric H Yang; Arnold S Baas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 6.  Targets for therapy in sarcomeric cardiomyopathies.

Authors:  Jil C Tardiff; Lucie Carrier; Donald M Bers; Corrado Poggesi; Cecilia Ferrantini; Raffaele Coppini; Lars S Maier; Houman Ashrafian; Sabine Huke; Jolanda van der Velden
Journal:  Cardiovasc Res       Date:  2015-01-29       Impact factor: 10.787

Review 7.  Myosin binding protein C: implications for signal-transduction.

Authors:  Ralph Knöll
Journal:  J Muscle Res Cell Motil       Date:  2011-12-16       Impact factor: 2.698

8.  Potential of (99m)Tc-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice.

Authors:  Takemi Rokugawa; Tomoya Uehara; Yusuke Higaki; Shuuichi Matsushima; Atsushi Obata; Yasushi Arano; Kohji Abe
Journal:  EJNMMI Res       Date:  2014-10-09       Impact factor: 3.138

9.  Accelerated (99m)Tc-sestamibi clearance associated with mitochondrial dysfunction and regional left ventricular dysfunction in reperfused myocardium in patients with acute coronary syndrome.

Authors:  Atsuro Masuda; Keiichiro Yoshinaga; Masanao Naya; Osamu Manabe; Satoshi Yamada; Hiroyuki Iwano; Tatsuya Okada; Chietsugu Katoh; Yasuchika Takeishi; Hiroyuki Tsutsui; Nagara Tamaki
Journal:  EJNMMI Res       Date:  2016-05-12       Impact factor: 3.138

Review 10.  Hypertrophic cardiomyopathy: a heart in need of an energy bar?

Authors:  Styliani Vakrou; M Roselle Abraham
Journal:  Front Physiol       Date:  2014-08-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.